Literature DB >> 19858064

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations.

David M Cook, Kevin C J Yuen, Beverly M K Biller, Stephen F Kemp, Mary Lee Vance.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19858064     DOI： 10.4158/EP.15.6.580

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  16 in total

1.  Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method.

Authors:  G Migliaretti; S Ditaranto; C Guiot; S Vannelli; P Matarazzo; N Cappello; I Stura; F Cavallo
Journal:  J Endocrinol Invest       Date:  2018-01-09       Impact factor: 4.256

2.  Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Authors:  G Aimaretti; R Attanasio; S Cannavò; M C Nicoletti; R Castello; C Di Somma; P Garofalo; L Iughetti; S Loche; M Maghnie; L Mazzanti; G Saggese; M Salerno; G Tonini; V Toscano; S Zucchini; M Cappa
Journal:  J Endocrinol Invest       Date:  2014-11-02       Impact factor: 4.256

3.  Variation of the baseline characteristics and treatment parameters over time: an analysis of 15 years of growth hormone replacement in adults in the German KIMS database.

Authors:  I Kreitschmann-Andermahr; S Siegel; F Francis; M Buchfelder; H J Schneider; P H Kann; H Wallaschofski; M Koltowska-Häggström; G Brabant
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

4.  A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening.

Authors:  Nicholas A Tritos; Thomas N Byrne; Chin-Lee Wu; Anne Klibanski
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

5.  Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.

Authors:  Daniel F Kelly; Charlene Chaloner; Diana Evans; Amy Mathews; Pejman Cohan; Christina Wang; Ronald Swerdloff; Myung-Shin Sim; Jihey Lee; Mathew J Wright; Claudia Kernan; Garni Barkhoudarian; Kevin C J Yuen; Kevin Guskiewicz
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

6.  Low prevalence of growth hormone deficiency in Turkish patients with Hashimoto's thyroiditis.

Authors:  S Akin; K Aydin; Ö A Gürlek
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

7.  Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency.

Authors:  Kevin C J Yuen; Jan Frystyk; Sharon A Rhoads; Martin Bidlingmaier
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

8.  Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.

Authors:  Kevin C J Yuen
Journal:  ISRN Endocrinol       Date:  2011-08-11

9.  Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.

Authors:  Lorenzo Iughetti; Gianluca Tornese; Maria Elisabeth Street; Flavia Napoli; Claudia Giavoli; Franco Antoniazzi; Stefano Stagi; Caterina Luongo; Sara Azzolini; Letizia Ragusa; Gianni Bona; Clara Zecchino; Tommaso Aversa; Luca Persani; Laura Guazzarotti; Emiliano Zecchi; Alberto Pietropoli; Stefano Zucchini
Journal:  Ital J Pediatr       Date:  2016-11-03       Impact factor: 2.638

Review 10.  Association of growth hormone deficiency (GHD) with anxiety and depression: experimental data and evidence from GHD children and adolescents.

Authors:  Fotini-Heleni Karachaliou; Kyriaki Karavanaki; Aristofania Simatou; Eleni Tsintzou; Nikitas S Skarakis; Christina Kanaka-Gatenbein
Journal:  Hormones (Athens)       Date:  2021-07-01       Impact factor: 2.885
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.